Your Health, We Care
brigatinib is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
from FDA，2022.02
Indications and Mechanism of Action of BrigatinibBrigatinib is used to treat adult patients with advanced non-small cell lung cancer, especially those whose tumors have a genetic d···【more】
Article source：Lucius LaosRelease date：2026-05-22Recommended：74
Mechanism of Action of Brigatinib (Alunbrig)Brigatinib (Alunbrig) is an oral prescription targeted therapy drug belonging to the class of tyrosine kinase inhibitors (TKIs). It work···【more】
Article source：Lucius LaosRelease date：2026-05-21Recommended：59
The treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：42
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
